New Center

• 9th May, 2020. Sino Biological sponsored a free webinar on SARS-CoV-2 (Covid-19) vaccine development. Click to learn more!

• 30th Apr, 2020. GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-CoV-2 (COVID-19) Vaccine Development. Learn more>>

• 16th Apr, 2020. Sino Biological Partners with Nanommune Inc. to Develop and Market a Novel Coronavirus Multiplex Serological Assay, Sinommune^TM. Learn more>>

• 31st March, 2020. Sino Biological Inc. will launch the world largest recombinant viral antigen collection, ProVir^TM, on April 1st. Learn more>>

• 19th March, 2020. Sino Biological Inc. has received support from the Bill & Melinda Gates foundation for the colloidal gold and ELISA based diagnosis of COVID-19. Learn more>>

• 22nd Jan, 2020. Sino Biological is the first company worldwide to offer recombinant proteins of SARS-CoV-2. Learn more>>

• 18th May, 2020. Researchers at Humabs Biomed SA and the University of Washington recently published a Nature article demonstrating the cross-neutralization of SARS-CoV-2 (Covid-19) using a monoclonal antibody recognizing three SARS RBD spike protein antigens (cat. numbers 40592-V31H, 40592-V05H and 40150-V08B1) developed at Sino Biological. Click this link to read the article!

• 13rd May, 2020. Researchers at Peking University and Beijing Youan Hospital jointly find a potent neutralizing antibodies against SARS-CoV-2 from convalescent patients identified by high-throughput single-cell sequencing of B cells. Sino Biological provide the the technical assistance on mAbs expression and characterization. Click this link to read the article!